Jones Financial Companies Lllp Acquires 1,316 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Jones Financial Companies Lllp boosted its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 982.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,450 shares of the company’s stock after purchasing an additional 1,316 shares during the period. Jones Financial Companies Lllp’s holdings in Ryan Specialty were worth $93,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the company. Sanctuary Advisors LLC grew its holdings in Ryan Specialty by 1.2% during the 4th quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company’s stock valued at $1,045,000 after purchasing an additional 188 shares during the last quarter. State of Alaska Department of Revenue grew its stake in Ryan Specialty by 1.6% in the 4th quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company’s stock worth $778,000 after acquiring an additional 190 shares in the last quarter. CIBC Asset Management Inc grew its stake in Ryan Specialty by 5.6% in the 4th quarter. CIBC Asset Management Inc now owns 3,674 shares of the company’s stock worth $236,000 after acquiring an additional 196 shares in the last quarter. Loomis Sayles & Co. L P grew its stake in Ryan Specialty by 26.3% in the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock worth $91,000 after acquiring an additional 286 shares in the last quarter. Finally, Exchange Traded Concepts LLC grew its stake in Ryan Specialty by 2.6% in the 4th quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company’s stock worth $755,000 after acquiring an additional 295 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors.

Ryan Specialty Trading Up 2.3 %

NYSE:RYAN opened at $69.86 on Monday. Ryan Specialty Holdings, Inc. has a 52 week low of $48.48 and a 52 week high of $75.97. The firm has a 50 day moving average of $67.11 and a 200 day moving average of $67.76. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a market capitalization of $18.30 billion, a price-to-earnings ratio of 101.25, a PEG ratio of 1.19 and a beta of 0.71.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The firm had revenue of $663.53 million for the quarter, compared to analysts’ expectations of $658.80 million. As a group, sell-side analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th will be given a dividend of $0.12 per share. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend is Tuesday, March 4th. This represents a $0.48 dividend on an annualized basis and a yield of 0.69%. Ryan Specialty’s dividend payout ratio is presently 69.57%.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 31,409 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the transaction, the director now owns 2,697 shares in the company, valued at approximately $177,031.08. This represents a 92.09 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders sold 246,451 shares of company stock valued at $16,214,293 over the last 90 days. Insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Wells Fargo & Company upped their target price on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a research note on Friday, February 21st. Morgan Stanley assumed coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price on the stock. Royal Bank of Canada dropped their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a research note on Friday, February 21st. UBS Group upped their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. Finally, Barclays upped their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. One analyst has rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Ryan Specialty currently has an average rating of “Hold” and an average price target of $75.27.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.